Join to View Full Profile
700 Lawrence ExpySanta Clara, CA 95051
Phone+1 510-219-3884
Fax+1 619-543-7277
Dr. Nikanjam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
Kaiser Permanente Northern California (Oakland)Residency, Internal Medicine, 2011 - 2014
University of California San Diego School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2012 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- High Dose IL-2 in Combination With Anti-PD-1 in Metastatic Melanoma and Renal Cell Carcinoma
- High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma Start of enrollment: 2019 May 23
- Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer Start of enrollment: 2019 Oct 08
Publications & Presentations
PubMed
- Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure.Steven Sun, Mina Nikanjam, Mark Mirochnick, Kathleen M Powis, Ahizechukwu C Eke
Journal of Clinical Pharmacology. 2026-01-01 - Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System.Mina Nikanjam, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Sarabjot Pabla
Cancer Medicine. 2026-01-01 - Cracking the resistance code: The molecular reclassification of cancer and precision therapy strategies.Mina Nikanjam, Razelle Kurzrock
Seminars in Cancer Biology. 2025-12-01
Press Mentions
Targeted Fusions Effective for Higher Response Rates and Longer PFSDecember 23rd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
